AI assistant
Antares Vision AGM Information 2022
4255_rns_2022-11-26_92098794-9615-49f1-bb3c-7bb0b826736c.pdf
AGM Information
Open in viewerOpens in your device viewer
ANTARES VISION S.P.A.: SIGNING OF THE DEED OF MERGER BY INCORPORATION OF CONVEL S.R.L.
Travagliato (BS), November 26, 2022 – Antares Vision S.p.A. (Antares Vision or the Company) informs that the deed of merger by incorporation of Convel S.r.l. with sole shareholder (Convel) into Antares Vision was executed yesterday, November 25, 2022, as per the resolutions of the Board of Directors of the Company held on 7 September 2022 and of the Shareholders' Meeting of Convel held on the same date (the Merger).
It is recalled that, since Convel is at the date of execution of the deed of Merger directly and wholly owned by Antares Vision and no Antares Vision shares are due to the shareholders of the merging company, the Merger results in the cancellation of Convel's corporate capital.
There are no special benefits in favour of the directors of the companies participating in the Merger.
The Merger, once the relevant deed is filed and registered with the competent Companies Register, will become effective as of 1 January 2023. As of that date, Antares Vision will take over all legal relations - assets and liabilities - belonging to Convel.
ABOUT ANTARES VISION
Antares Vision Group is an outstanding technology partner in digitalization and innovation for companies and institutions, guaranteeing the safety of products and people, business competitiveness as well as environmental protection. The Company provides a unique and comprehensive ecosystem of technologies to guarantee product quality (inspection systems and equipment) and end-to-end product traceability (from raw materials to production, from distribution to the consumer) through integrated data management, applying artificial intelligence and blockchain technology. The Antares Vision Group is active in Life Science (pharmaceutical, biomedical devices and hospitals) and in FMCG (Fast-Moving Consumer Goods). As a world leader in Track & Trace solutions for pharmaceutical products, the Company provides major global manufacturers (over 50% of the top 20 multinationals) and numerous government authorities with solutions, monitoring their supply chains and validating product authenticity. Listed since April 2019 on the Italian Stock Exchange in the AIM (Alternative Investment Market) segment, and from 14 May 2021 in Euronext STAR Milan. Antares Vision Group recorded a turnover of €179 million in 2021, operates in 60 countries, employs more than 1000 people and has a consolidated network of over 40 international Partners. Further information please visit www.antaresvision.com and www.antaresvisiongroup.com.
For further information
Antares Vision Group Alessandro Baj Badino Head of Investor Relations Tel.: +39 030 72 83 500 E-mail: [email protected]
Davide Antonioli Investor Relator +39 030 7283500 [email protected]